Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection

The virus “acute respiratory syndrome coronavirus 2” (SARS-CoV-2) is the etiologic agent of coronavirus disease 2019 (COVID-19), initially responsible for an outbreak of pneumonia in Wuhan, China, which, due to the high level of contagion and dissemination, has become a pandemic. The clinical pictur...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Júlia Leão Batista, de Araújo, Julia Beatrice, Bagatini, Margarete Dulce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272687/
https://www.ncbi.nlm.nih.gov/pubmed/34247339
http://dx.doi.org/10.1007/s12035-021-02464-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272687/
https://www.ncbi.nlm.nih.gov/pubmed/34247339
http://dx.doi.org/10.1007/s12035-021-02464-0

Ejemplares similares